Compartir
Información de la revista
Número
Vol. 27. Núm. S3.Abstracts from XVII Mexican Congress of Hepatology
(diciembre 2022)
Abstracts Asociación Mexicana del Hígado (AMH)
Ann Hepatol. 2022;27 Supl 3:100782
Acceso a texto completo
Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study
AB Moreno-Cobos, F Higuera-de la Tijera, CI Hinojosa-Segura, D Montemira-Orozco, J Reyes-Méndez, IG Cruz-Reyes, J Zavala-Ramírez, D Santana-Vargas, ... JL Pérez- Hernandez
Ann Hepatol. 2022;27 Supl 3:100782.1
Open access
Short-term response of p300 evoked potential in patients with minimal hepatic encephalopathy treated with l-ornithine, l-aspartate
CI Hinojosa-Segura, D Montemira-Orozco, A Burak-Leipuner, J Zavala-Ramírez, IG Cruz-Reyes, M Escobedo-Silva, F Higuera-de la Tijera, JL Pérez-Hernández, D Santana-Vargas
Ann Hepatol. 2022;27 Supl 3:100782.2
Open access
The Stroop test validation in the detection of minimal hepatic encephalopathy in Mexican patients with cirrhosis, preliminary results
PF Domínguez Cardoso, JL Pérez Hernández, F Higuera de la Tijera, AD Santana Vargas, D Montemira Orozco, CI Hinojosa Segura
Ann Hepatol. 2022;27 Supl 3:100782.3
Open access
Changes in early visual perception in patients with minimal hepatic encephalopathy
D Montemira-Orozco, CI Hinojosa-Segura, A Burak-Leipuner, J Zavala-Ramírez, IG Cruz-Reyes, M Escobedo-Silva, F Higuera-de la Tijera, JL Pérez-Hernández, D Santana-Vargas
Ann Hepatol. 2022;27 Supl 3:100782.4
Open access
Sarcopenia as a predictor of risk of minimal hepatic encephalopathy in patients with liver cirrhosis
O Morales Gutiérrez, A Burak Leipuner, P Alagón Fernandez de Campo, F Vargas Duran, CI Hinojosa Segura, D Montemira Orozco, AD Santana Vargas, MF Higuera de la Tijera, JL Pérez Hernández
Ann Hepatol. 2022;27 Supl 3:100782.5
Open access
Prevalence of liver fibrosis determined by non-invasive methods in patients with metabolic disorders at the Centro Medico Nacional 20 de noviembre
KG Peña-Genaro, E Buganza-Torio, M Ramos-Gómez
Ann Hepatol. 2022;27 Supl 3:100782.6
Open access
Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients
A Burak-Leipuner, F García-Gorrosquieta, N Uribe-Rivera, A Servín-Caamaño, JA Romero-Bermúdez, LE Ceceña-Martínez, P Alagón-Fernández del Campo, FY Vargas-Duran, ... F Higuera-de la Tijera
Ann Hepatol. 2022;27 Supl 3:100782.7
Open access
The usefulness of 3 different points of the liver to evaluate fibrosis by transitional elastography
E Morales-Mairena, MF Higuera-de-la Tijera, DA Santana Vargas, E Rene Borages, A Burak Leipuner, IA García Espinosa, F García Juárez, JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.8
Open access
Liquid biopsy of patients with advanced liver fibrosis reveals the association of methylation in CpGs and miRNAs expression with the degree of severity
R De la Rosa-Bibiano, R Escutia-Gutiérrez, S Rodríguez-Sanabria, E Cerda-Reyes, JM Aguilar, A Santos, AS Sandoval-Rodríguez, J Armendáriz-Borunda
Ann Hepatol. 2022;27 Supl 3:100782.9
Open access
Increase in liver fibrosis in patients with inflammatory bowel disease at the inflammatory bowel disease clinic, Centro Medico Nacional 20 de noviembre
IE Severino-Ferreras, LO Rodríguez-Muñoz, JG Lopez-Gómez
Ann Hepatol. 2022;27 Supl 3:100782.10
Open access
Effect of zinc supplementation in patients with cirrhosis and dysgeusia
E. Juárez-Hernández, I. López-Méndez, M. Uribe, N. Chávez-Tapia
Ann Hepatol. 2022;27 Supl 3:100782.11
Open access
6-Week mortality predictors in patients with acute variceal bleeding from the western national medical center of the Mexican social security institute
UI Martín-Flores, JF Aguayo-Villaseñor, ME Contreras-Marín
Ann Hepatol. 2022;27 Supl 3:100782.12
Open access
An unusual complication after variceal band ligation: complete esophageal obstruction, a case report and review of the literature
M Figueroa-Palafox, E Juarez- Hernandez, YI López-Mendéz
Ann Hepatol. 2022;27 Supl 3:100782.13
Open access
Comparison of the meld-la model as a predictor of early mortality in Mexican patients with chronic decompensated liver disease
A Enríquez-Constantino, F Higuera-de la Tijera, E Morales-Mairena, V Hernandez-Gárza, JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.14
Open access
Norepinephrine in infusion as an alternative to large volume post-paracentesis albumin in patients with cirrhosis
E Morales-Mairena, F Higuera-de la Tijera, A Enríquez-Constantino, DA Santana Vargas, JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.15
Open access
Management of internal hemorrhoidal bleeding refractory to endoscopic treatment in a patient with liver cirrhosis
JP Soriano-Márquez, FJ Ayala-Ochoa, J Guerrero-Ixtlahuac, E Juárez-Hernández, G Castro-Narro, I López-Mendéz
Ann Hepatol. 2022;27 Supl 3:100782.16
Open access
Causes of decompensation of liver cirrhosis and predictors of in-hospital mortality in patients admitted to the gastroenterology service of the Regional Hospital Lic. Adolfo López Mateos in the years 2017 - 2018
M Velasco Gutiérrez, M Ortiz Aguirre, EG Salgado Parra
Ann Hepatol. 2022;27 Supl 3:100782.17
Open access
Hepatic hydrothorax resistant to diuretics treated with octreotide
S Teutli-Carrión, C Sánchez-Sánchez, E Medina-Ávalos, M Carmona-Castillo, C Dorantes-Nava, F Higuera-de la Tijera, JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.18
Open access
Efficacy and safety of treatment with terlipressin infusion vs. bolus in gastrointestinal bleeding of variceal origin in a third-level hospital
N Moreno Aguilar, DE Meléndez Mena, MA Mendoza Torres
Ann Hepatol. 2022;27 Supl 3:100782.19
Open access
Evaluation of the early response to empirical treatment and its association with cultures in patients with spontaneous bacterial peritonitis (SBP)
ST Carrión, F Garcia-Juarez, P Diego-Salazar, E Medina-Ávalos, M Carmona-Castillo, C Dorantes-Nava, F Higuera-de la Tijera, JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.20
Open access
MELD Na and MELD 3.0 have the best performance in predicting the risk of death at 28 days in patients with severe alcoholic hepatitis in the Mexican population
CL Dorantes-Nava, F Higuera-de la Tijera, A Servín-Caamaño, F Salas-Gordillo, JM Abdo-Francis, G Gutiérrez-Reyes, P Diego-Salazar, MY Carmona-Castillo, ... JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.21
Open access
Characterization of acute kidney injury among Mexican patients with cirrhosis
MY Carmona-Castillo, F Higuera-de la Tijera, JL Pérez-Hernández, CS Tinitana -Jumbo, S Teutli-Carrion, EJ Medina–Avalos, CL Dorantes-Nava
Ann Hepatol. 2022;27 Supl 3:100782.22
Open access
Etiology and find in portal vein thrombosis at the Hospital de Especialidades del Centro Médico Nacional La Raza
G Morales Osorio, GD Salazar-Hinojosa, AY Cruz-Saucedo, M Castillo-Barradas, CM del Real Calzada, MT Rizo-Robles
Ann Hepatol. 2022;27 Supl 3:100782.23
Open access
Prevalence of hepatobiliary manifestations and its relationship with the time of evolution of inflammatory bowel disease in patients attended at Centro Médico Nacional 20 de noviembre
LO Rodríguez Muñoz, IE Severino Ferreras, JL Hernández Lecona, JG López Gómez, M Narváez Méndez, KG Peña Genao
Ann Hepatol. 2022;27 Supl 3:100782.24
Open access
Precipitating factors of kidney injury in patients with liver cirrhosis
F Sánchez Salinas, T Deaquino Reyes, R Chicas López, S Mejía Loza, EI Juárez Valdés
Ann Hepatol. 2022;27 Supl 3:100782.25
Open access
Frequency of the association of metabolic syndrome in patients with liver cirrhosis hospitalized for variceal hemorrhage at Hospital Juárez de México
T Deaquino Reyes, F Sánchez Salinas, C Mendoza Sangeado, S Mejía Loza
Ann Hepatol. 2022;27 Supl 3:100782.26
Open access
Prevalence of hepatobiliary manifestations in patients with inflammatory bowel disease
JI Carrillo Rojas, F Martinez Silva, S Ontiveros López, MC Bernardino del Rio, A Torres Castro, CJ Toranzo González
Ann Hepatol. 2022;27 Supl 3:100782.27
Open access
Left-sided portal hypertension as a complication of chronic pancreatitis in a young patient. A case report
CL Dorantes-Nava, F Higuera-de la Tijera, A Servín-Caamaño, F Salas-Gordillo, JM Abdo-Francis, G Gutiérrez-Reyes, MY Carmona-Castillo, S Teutli- Carrion, ... JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.28
Open access
Frequency of bleeding due to ulcer associated with H. Pylori (HP) in patients with liver cirrhosis at Hospital Juárez de México
R Mendoza Sangeado, T Deaquino Reyes, F Sánchez Salinas, S Mejía Loza
Ann Hepatol. 2022;27 Supl 3:100782.29
Open access
Notable intestinal dysbiosis orchestrated by Escherichia/Shigella, decreased levels of SCFTA (short chain fatty acids) and alterations in metabolic pathways characterize patients with alcohol-decompensated cirrhosis in western Mexico
TA Baltazar-Díaz, LA González-Hernández, JM Aldana-Ledesma, M Peña-Rodríguez, AN Vega-Magaña, ASM Zepeda-Morales, RI López-Roa, S Del Toro-Arreola, MR Bueno-Topete
Ann Hepatol. 2022;27 Supl 3:100782.30
Open access
Epidemiologic profile of non-alcoholic fatty liver disease in apparently healthy blood bank donors
JE Lira-Vera, O Morales-Gutiérrez, FY Vargas-Durán, P Alagón-Fernández del Campo, AK Soto Martínez, D Montemira-Orozco, A Burak-Leipuner, C Hinojosa-Segura, ... JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.31
Open access
Susceptibility to liver damage in women due to risky alcohol consumption
E Morales-Mairena, F Higuera-de la Tijera, A Enríquez-Constantino, DA Santana Vargas, JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.32
Open access
Differences in mortality and prognostic scales according to ACLF grade
R Nava-Arceo, BA Priego-Parra, P González-Ballesteros
Ann Hepatol. 2022;27 Supl 3:100782.33
Open access
Acute-on-chronic liver failure or Alcoholic Hepatitis? In patients with chronic alcoholic liver disease
R Chicas López, S Mejía Loza, O García Rodas, L Pinto García, F Sánchez Salinas, C Jaen Villanueva, P Guillermo, G Castañón García
Ann Hepatol. 2022;27 Supl 3:100782.34
Open access
Characteristics of patients with acute over chronic liver failure (ACLF) and risk of mortality due to amount of alcohol, MELD and MELD NA
EJ Medina Avalos, MF Higuera de la Tijera, JL Pérez Hernández, MY Carmona Castillo, S Teutli Carrión, CL Dorantes Nava, G Rangel Zavala
Ann Hepatol. 2022;27 Supl 3:100782.35
Open access
Characterization of primary biliary cholangitis in a Mexican population in patients from the Hospital General de México
PF Domínguez Cardoso, F Higuera de la Tijera, V López Ladrón de Guevara
Ann Hepatol. 2022;27 Supl 3:100782.36
Open access
Autoimmune hepatitis (HAI) is likely induced by Epstein Barr Virus (EBV) infection
EJ Medina Avalos, FI García Juárez, JL Pérez Hernández, MY Carmona Castillo, ST Carrión, CL Dorantes Nava
Ann Hepatol. 2022;27 Supl 3:100782.37
Open access
Reactivation autoimmune hepatitis report of two cases
CJ Toranzo González, M Castillo Barradas, A Torres Castro
Ann Hepatol. 2022;27 Supl 3:100782.38
Open access
Overlay of autoimmune cholangitis and autoimmune hepatitis
KM Cervantes Espinoza, L Juárez Chávez, DG Ibarra Salazar
Ann Hepatol. 2022;27 Supl 3:100782.39
Open access
Accuracy of NVP score as a predictor of gastroesophageal varices in primary biliary cholangitis
RA Miranda Maciel, OM Montoya, SMI Mejía Loza, T Deaquino Reyes, A Pacheco Montes
Ann Hepatol. 2022;27 Supl 3:100782.40
Open access
Trends of autoimmune liver diseases in the University Hospital, UANL for 26 years. A single-center experience in Mexico
LE Munoz-Espinosa, C Treviño-Garcia, I Lopez-Reyna, A Regalado-Ceballos, P Cordero-Perez, VH Avalos-Gomez, RH Gutierrez-Carrillo, BB Alcocer-Galvan, LM Barbosa-Castillo
Ann Hepatol. 2022;27 Supl 3:100782.41
Open access
Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of Hepatitis C
J Mendez-Navarro, J Turnes, A García-Herola, R Morillo, M Méndez, M Rueda, C Hernández, A Sicras-Mainar
Ann Hepatol. 2022;27 Supl 3:100782.42
Open access
Screening program for hepatitis c virus in an open population at a third-level healthcare center
F Higuera-de la Tijera, E Rodríguez-Fuentes, ML Hernández-Medel, JL Pérez-Hernández, R Serrano-Loyola, GML Guerrero-Avendaño
Ann Hepatol. 2022;27 Supl 3:100782.43
Open access
Use of glecaprevir and pibrentasvir as rescue therapy in patients with resistance to direct-acting antiviral agents
LS Juarez Chavez, JS Sandoval Mendoza
Ann Hepatol. 2022;27 Supl 3:100782.44
Open access
Treatment with nucleoside and nucleotide analogues in patients with chronic hepatitis B virus infection
CA González Rodríguez, A Bautista Santos, R Moreno Alcántar
Ann Hepatol. 2022;27 Supl 3:100782.45
Open access
Spontaneous elimination of the Hepatitis C virus at the CMN la Raza specialty hospital
AY Cruz Saucedo, GD Salazar-Hinojosa, G. Morales-Osorio, V. Rodríguez-Granados, C.M. del Real Calzada, M.T. Rizo-Robles
Ann Hepatol. 2022;27 Supl 3:100782.46
Open access
Incidence and risk factors of Chronic Viral Hepatitis type C in persons deprived of their liberty in the Social Rehabilitation Center (CERESO) of the state of Veracruz
MT Guzmán Terrones, M Alfaro Centeno, LÁ Cortez Lara, IM Pérez Acosta
Ann Hepatol. 2022;27 Supl 3:100782.47
Open access
Detection of Hepatitis C and risk factors in the general population of the Centro Médico Nacional La Raza
GD Salazar Hinojosa, G Morales-Osorio, MT Rizo-Robles, AY Cruz-Saucedo, CM del Real Calzada
Ann Hepatol. 2022;27 Supl 3:100782.48
Open access
Metabolic-associated fatty liver disease (MAFLD) is not associated with bone mineral density (BMD) alterations in Mexican women: a cross-sectional study
GN López-Sánchez, N Martínez-Zavala, P Alberti-Minutti, A Vergara-Lopez, N Chavéz-Tapia, M Uribe, N Nuño-Lámbarri
Ann Hepatol. 2022;27 Supl 3:100782.49
Open access
Mediterranean diet vs. regional diet in a Mexican population with MAFLD: 3-month cohort
MJJ García-Carvajal, AD Cano-Contreras, MR Francisco, HR Ordaz-Álvarez, SA Reyes-Díaz, M Vieyra-Vega, JM Remes-Troche
Ann Hepatol. 2022;27 Supl 3:100782.50
Open access
Prevalence of non-alcoholic fatty liver disease in apparently healthy blood bank donors: metabolic, alcohol, and combined damage
JE Lira-Vera, O Morales-Gutiérrez, FY Vargas-Durán, P Alagón-Fernández del Campo, AK Soto Martínez, D Montemira-Orozco, A Burak-Leipuner, C Hinojosa-Segura, ... JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.51
Open access
Changes in physical activity and its impact on MAFLD during the COVID-19 pandemic
MJJ García-Carvajal, AD Cano-Contreras, MR Francisco, HR Ordaz-Álvarez, SA Reyes-Díaz, M Vieyra-Vega, JC Ortiz-Zarate, JM Remes-Troche
Ann Hepatol. 2022;27 Supl 3:100782.52
Open access
Association between hypothyroidism and non-alcoholic fatty liver disease
J Zuarth-Vázquez, JP Soriano-Márquez, A Velázquez-Alemán, L Moreno-Castañeda, I López-Méndez, MH Ramos-Ostos, M Uribe, E Juárez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.53
Open access
Prevalence of high-risk non-alcoholic steatohepatitis according to the fast® index in a group of diabetic patients
A Burak-Leipuner, F Higuera-de la Tijera, A Servín-Caamaño, J Romero-Bermúdez, L Ceceña-Martínez, F García-Gorrosquieta, N Uribe-Rivera, P Alagón-Fernández del Campo, ... JL Pérez-Hernández
Ann Hepatol. 2022;27 Supl 3:100782.54
Open access
Manifestations of SARS-COV-2 in patients with chronic liver disease
AE Jiménez-Partida, MA Jiménez-Luévano, MA Jiménez-Partida, A Bravo-Cuellar, Y Cortes-Aguilar
Ann Hepatol. 2022;27 Supl 3:100782.55
Open access
Pilot study: management with pentoxifylline in patients with chronic liver disease and COVID-19
MA Jiménez-Luévano, AE Jiménez-Partida, MA Jiménez-Partida, A Bravo-Cuellar, Y Cortes-Aguilar
Ann Hepatol. 2022;27 Supl 3:100782.56
Open access
To present a clinical case of a 52-year-old female patient with a diagnosis of pyogenic liver abscesses
RJ Ortega-García
Ann Hepatol. 2022;27 Supl 3:100782.57
Open access
Acute liver failure and experience with therapy using the molecular absorbent recirculation system (MARS)
FI García-Juárez, I García-Espinosa, VM Páez-Zayas, A Sánchez-Cedillo, A Pérez-Calatayud, F Higuera-de-la-Tijera, JL Perez-Hernandez
Ann Hepatol. 2022;27 Supl 3:100782.58
Open access
Congenital hepatic fibrosis as a rare cause of non-cirrhotic portal hypertension
MO Santana Montes, VM Páez Zayas, MF Higuera De la Tijera, JL Pérez-Hernández, LG Ruíz-Fabian, D Montante-Montes de Oca, VH Méndez Cano
Ann Hepatol. 2022;27 Supl 3:100782.59
Open access
Sclerosing cholangitis associated with IgG4 disease. Case Report
A Torres Castro, M Castillo Barradas, CJ Toranzo González, M Cristina Bernardino
Ann Hepatol. 2022;27 Supl 3:100782.60
Open access
Giant simple hepatic cyst, when and how to treat it
IA García Espinosa, MY Carmona- Castillo, FI García-Juárez, JL Pérez-Hernández, F Higuera-de-la-Tijera
Ann Hepatol. 2022;27 Supl 3:100782.61
Open access
Symptomatic giant cavernous hemangioma as an indication for liver transplantation
IA García Espinosa, FI García-Juárez, VM Páez-Zayas, JL Pérez-Hernández, F Higuera-de-la-Tijera
Ann Hepatol. 2022;27 Supl 3:100782.62
Open access
Tyrosinemia in a toddler, a case report
GA Gómez Vidrio, M Lescas Orozco, MR Lara Tostado, I Suárez Ponce, FA Reynoso Zarzosa
Ann Hepatol. 2022;27 Supl 3:100782.63
Open access
Post-infantile giant cell hepatitis, management, six-year follow-up and re-transplantation, a successful case report during the pandemic
R Sosa Martínez, E Buganza Torio, MC Ramos Gómez, E Goudet Vertiz
Ann Hepatol. 2022;27 Supl 3:100782.64
Open access
Autoimmune hemolytic anemia as a paraneoplastic syndrome in hepatocarcinoma, case report
MC Alegría-Ovando, AM Torales-Gamboa, BA Herrera-Chi
Ann Hepatol. 2022;27 Supl 3:100782.65
Open access
Complete genome sequence of Hepatitis C Virus isolated in Mexico
K López-Riojas, KA Galán-Huerta, AF Ruiz-Higareda, L Muñoz-Espinosa, P Cordero-Pérez, D Arellanos-Soto, S Lozano-Sepulveda, AM Rivas-Estilla
Ann Hepatol. 2022;27 Supl 3:100782.66
Open access
Identification of resistance mutations to DAA's against Hepatitis C Virus in infected subjects in Mexico
K López-Riojas, KA Galán-Huerta, AF Ruiz-Higareda, L Muñoz-Espinosa, P Cordero-Pérez, D Arellanos-Soto, S Lozano-Sepúlveda, AM Rivas-Estilla
Ann Hepatol. 2022;27 Supl 3:100782.67
Open access
Hepatitis C virus NS5A and core proteins regulate epithelial-mesenchymal transition biomarkers in hepatoma cells
TG Heredia-Torres, SA Lozano-Sepúlveda, AR Rincón-Sánchez, AMG Rivas-Estilla
Ann Hepatol. 2022;27 Supl 3:100782.68
Open access
Diethylnitrosamine and 2-acetylaminofluorene chronic administration leads to biochemical and histologic changes related to hepatocellular carcinoma in Wistar rats
J Sánchez-Meza, M Campos-Valdez, JA Domínguez-Rosales, SC Rodríguez-Reyes, E Martínez-López, JM Godínez-Rubí, LV Sánchez-Orozco
Ann Hepatol. 2022;27 Supl 3:100782.69
Open access
In vitro evaluation of the antifibrogenic effect of tamsulosin during its interaction with activated stellate cells
RJ Buendía-Delgado, R Guerrero-Alba, SL Martínez-Hernández, MH Muñoz-Ortega, MY Medina-Pizaño
Ann Hepatol. 2022;27 Supl 3:100782.70
Open access
Assessment of cellular proliferation, death and senescence in a model of steatosis in vitro
A Campos-Espinosa, G Gutiérrez-Reyes, C Guzmán
Ann Hepatol. 2022;27 Supl 3:100782.71
Open access
The administration of pirfenidone modifies the expression of JMJD2B in a murine model of NASH
JS Rodriguez Sanabria, J García Bañuelos, R Escutia Gutiérrez, CA Monraz Méndez, A Santos, J Armendáriz-Borunda, AS Sandoval Rodríguez
Ann Hepatol. 2022;27 Supl 3:100782.72
Open access
Evaluation of deubiquiyinase USP15 expression during HCV replication
L Bazaldúa-Ramos, AM Rivas-Estilla, SA Lozano-Sepúlveda
Ann Hepatol. 2022;27 Supl 3:100782.73
Open access
Pirfenidone regulates antioxidant response via NRF2 in an experimental model of hepatocellular carcinoma
HC Monroy-Ramírez, HO Miranda-Roblero, M Galicia-Moreno, A Santos-García, J Armendáriz-Borunda
Ann Hepatol. 2022;27 Supl 3:100782.74
Open access
Dietary supplementation with methyl donors improves physiopathological conditions of NAFLD in a murine model
A Vazquez Esqueda, R Rosas Campos, S Rodríguez Sanabria, R de la Rosa Bibiano, J Armendáriz Borunda, A Sandoval Rodríguez
Ann Hepatol. 2022;27 Supl 3:100782.75
Open access
Effects of in vitro lipid overload on LX-2 hepatic stellate cells
A Campos-Espinosa, G Gutiérrez-Reyes, C Guzmán
Ann Hepatol. 2022;27 Supl 3:100782.76
Open access
Moringa oleifera decreases biomarkers of oxidative stress in a murine NASH model
A Monraz-Méndez, R Escutia-Gutiérrez, JS Rodríguez-Sanabria, L Sánchez-Orozco, J Armendáriz-Borunda, A Sandoval-Rodríguez
Ann Hepatol. 2022;27 Supl 3:100782.77
Open access
Pirfenidone ameliorates MAFLD by improving insulin sensitivity and reducing epididymal fat
J. Gutiérrez-Cuevas, D López-Cifuentes, AS Sandoval-Rodríguez, AO Vázquez-Esqueda, JS Rodríguez-Sanabria, J Armendáriz-Borunda
Ann Hepatol. 2022;27 Supl 3:100782.78
Open access
Hepatoprotective effect of caffeine against ischemia-reperfusion damage
D Garza-Guzmán, L Torres-González, GR Govea-Torres, JM De la Rosa-García, CA Jiménez-Torres, DP Moreno-Peña, DR Rodríguez-Rodríguez, LE Muñoz-Espinosa, ... P Cordero-Pérez
Ann Hepatol. 2022;27 Supl 3:100782.79
Open access
Evaluation of the hypolipidemic effect of cinnamon essential oil in a model of acute damage induced by triton WR-1339
JM De la Rosa-García, P Cordero-Pérez, CA Jimenéz-Torrés, D Garza-Guzman, GR Govea-Torres, DR Rodríguez-Rodríguez, L Torres-González, LE Muñoz-Espinosa, DP Moreno-Peña
Ann Hepatol. 2022;27 Supl 3:100782.80
Open access
The gut microbiota and key parameters associated with MAFLD are modified by MEXMIX
R Rosas-Campos, A Meza-Ríos, S Rodríguez-Sanabria, R de la Rosa-Bibiano, A Santos, A Sandoval-Rodríguez, J Armendáriz-Borunda
Ann Hepatol. 2022;27 Supl 3:100782.81
Open access
Serum determination of IL-1β and IL-1RA in patients with chronic liver diseases
A Hernandez-Barragan, D Montes-de-Oca-Angeles, M Lemus-Peña, M Hernandez-Santillan, KZ Medina-Avila, M Martínez-Castillo, JL Pérez-Hernández, F Higuera-De la Tijera, ... G Gutiérrez-Reyes
Ann Hepatol. 2022;27 Supl 3:100782.82
Open access
Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
M Hernandez-Santillan, M Martínez-Castillo, Z Medina-Ávila, M Lemus-Peña, D Montes de Oca-Ángeles, A Hernández-Barragan, JL Pérez-Hernández, F Higuera-De la Tijera, ... G Gutiérrez-Reyes
Ann Hepatol. 2022;27 Supl 3:100782.83
Open access
Role of tamsulosin in recovery from thioacetamide-induced subchronic liver damage in a Wistar rat model
Samson Soleil, BA Marichal-Cansino, SL Martínez-Hernández, J Ventura-Juárez, MH Muñoz-Ortega
Ann Hepatol. 2022;27 Supl 3:100782.84
Open access
Hepatic MIR-122-3P, MIR-140-5P and MIR-148B-5P expressions are correlated with cytokeratin-18 serum levels in MAFLD
GN López-Sánchez, E Montalvo-Javé, NC Chavéz-Tapia, M Uribe, N Nuño-Lámbarri
Ann Hepatol. 2022;27 Supl 3:100782.85
Open access
Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C
M Lemus-Peña, D Montes de Oca-Ángeles, M Hernandez-Santillan, A Hernandez-Barragan, D Santana-Vargas, M Martinez-Castillo, Z Medina-Avila, A Torre-Delgadillo, ... G Gutiérrez-Reyes
Ann Hepatol. 2022;27 Supl 3:100782.86
Open access
MMP-7 is a non-invasive biomarker of chronic liver diseases
D Montes de Oca-Angeles, M Lemus-Peña, A Hernandez-Barragan, M Hernández-Santillán, M Martinez-Castillo, D Santana-Vargas, Z Medina-Avila, A Torre-Delgadillo, ... G Gutiérrez-Reyes
Ann Hepatol. 2022;27 Supl 3:100782.87
Open access
Autoimmune hepatitis with superimposition of primary sclerosing cholangitis on non-specific chronic ulcerative colitis
JS Sandoval Mendoza, L Juárez Chávez, DG Ibarra Salazar
Ann Hepatol. 2022;27 Supl 3:100782.88
Open access
Liver transplantation, experience at the general hospital of Mexico during the last four years
FI García Juárez, I García-Espinosa, DF Abendaó Rivera, EJ Medina Avalos, VM Páez-Zayas, A Sánchez-Cedillo, MF Higuera-de-la Tijera, JL Pérez Hernández
Ann Hepatol. 2022;27 Supl 3:100782.89
Open access
Jejunal lymphoma of large cell high grade B monomorphic in a patient with hepatic transplant
AD Trujillo Lejía, M Castillo Barradas, SA García Gutierrez, IM Montoya Fuentes, SE Romero Ramos
Ann Hepatol. 2022;27 Supl 3:100782.90
Open access
Publique en
Annals of Hepatology
Affiliated societies
